Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
22 March 2022 | Story André Damons
Dr Yolandi Swart
Dr Yolandi Swart, who took over from Prof Lynette van der Merwe as the new Director of the Undergraduate Medical Programme (MB ChB programme) in the School of Clinical Medicine within the Faculty of Health Sciences at the University of the Free State (UFS), says she is excited about the new opportunities that come with this position.

The new Director of the Undergraduate Medical Programme (MB ChB programme) in the School of Clinical Medicine within the Faculty of Health Sciences at the University of the Free State (UFS) has a passion for teaching and learning and brings a wealth of experience with her.

Dr Yolandi Swart, who took over from Prof Lynette van der Merwe on 1 March 2022, says she is excited about the new opportunities that this position brings. She was not actively job-hunting and came across the advertisement by accident but was thrilled when she was informed that she is the recommended candidate.

A deep love for the UFS

“I will be heading up an amazing team of people who drive the MB ChB programme, making sure that we walk with our students on their journey to become the next generation of health professionals who will contribute to the health and wellness of our population. Our functions include coordinating the undergraduate curriculum, providing student support, as well as logistic support to ensure the smooth running of the MB ChB programme,” says Dr Swart.

As an alumna of the university (she obtained both her MB ChB and postgraduate MMed in Community Health at the UFS), she has a deep love for the UFS, as it has played a huge role in developing her into the person she is today.

According to Dr Swart, she looks forward to getting to know the students and seeing them develop into the best they can be, as well as engaging with the academic staff as they guide and train the students. She brings a diverse background to the position, having practised as a doctor, specialised in Community Health, and worked in clinical research at various levels, including senior management. This has afforded her the opportunity to equip herself with skills that she hopes will provide support and direction to the Undergraduate Programme Management team in order to provide excellent service in all its functions.

Her vision

“I love teaching and learning – taking a concept and making it accessible to someone.  There are few things as satisfying as seeing that expression that says ‘Oh, now I get it!’

Kovsies has always had a reputation of producing excellent doctors.  “It is my vision to build on that reputation, integrating local and international best practices as they develop into our students’ training, with the aim of developing young professionals who are competent, resilient, and able to face the challenges that life will throw at them – so that they, in turn, can play their role to influence lives for the better.”

Prior to her appointment, she worked at FARMOVS as a clinical research physician for more than six years, the past year and a half as the company’s Medical Director. Says Dr Swart: “I love challenging myself with new things every so often. Past and present hobbies include surfing (which died an early death, as I was horrible at it), scuba diving (yes, with sharks as well), horse-riding, and self-defence.  Most recently, I got hooked on traditional archery – a very challenging skill to try and master.”

Dr Swart says she has learned throughout her personal life and professional career that life sometimes takes unexpected turns – but if one is open to the opportunities afforded by those unexpected turns, it often turns out so much better than the original plan could ever have been. “Difficulties and challenges will always come – but if one faces them with a positive attitude, they teach life skills that you would otherwise never have attained.”

News Archive

#Women'sMonth: Save the children
2017-08-10

Description: Trudi O'Neill Tags: : rotaviruses, young children, Dr Trudi O’Neill, Department of Microbial, Biochemical and Food Biotechnology, vaccine 

Dr Trudi O’Neill, Senior lecturer in the Department of
Microbial, Biochemical and Food Biotechnology.
Photo: Anja Aucamp

Dr Trudi O’Neill, Senior lecturer in the Department of Microbial, Biochemical and Food Biotechnology, is conducting research on rotavirus vaccines.

Dr O’Neill was inspired to conduct research on this issue through her fascination with the virus. “The biology of rotaviruses, especially the genome structure and the virus’ interaction with the host, is fascinating.”

“In fact, it is estimated that, globally, ALL children will be infected with rotavirus before the age of five, irrespective of their socio-economic standing. However, infants and young children in poor countries are more vulnerable due to inadequate healthcare. The WHO estimates that approximately 215 000 deaths occur each year. This roughly equates to eight Airbus A380 planes, the largest commercial carrier with a capacity of approximately 500 seats, filled with only children under the age of five, crashing each week of every year.”

Alternative to expensive medicines 
“Currently, there are two vaccines that have been licensed for global use. However, these vaccines are expensive and poor countries, where the need is the greatest, are struggling to introduce them sustainably. It is therefore appealing to study rotaviruses, as it is scientifically challenging, but could at the same time have an impact on child health,” Dr O’Neill said.

The main focus of Dr O’Neill’s research is to develop a more affordable vaccine that can promote child vaccination in countries/areas that cannot afford the current vaccines.

All about a different approach 

When asked about the most profound finding of her research, Dr O’Neill responded: “It is not so much a finding, but rather the approach. My rotavirus research group is making use of yeast as vehicle to produce a sub-unit vaccine. These microbes are attractive, as they are relatively easy to manipulate and cheap to cultivate. Downstream production costs can therefore be reduced. The system we use was developed by my colleagues, Profs Koos Albertyn and Martie Smit, and allows for the potential use of any yeast. This enables us to screen a vast number of yeasts in order to identify the best yeast producer.”

Vaccination recently acquired a bad name in the media for its adverse side effects. As researcher, Dr O’Neill has this to say: “Vaccines save lives. By vaccinating your child, you don’t just protect your own child from a potentially deadly infection, but also other children in your community that might be too young to be vaccinated or have pre-existing health problems that prevents vaccination.” 

A future without rotavirus vaccination?

Dr O’Neill believes a future without rotavirus vaccination will be a major step backwards, as the impact of rotavirus vaccines has been profound. “Studies in Mexico and Malawi actually show a reduction in deaths. A colleague in Mozambique has commented on the empty hospital beds that amazed both clinicians and scientists only one year after the introduction of the vaccine in that country. Although many parents, mostly in developed countries, don’t have to fear dehydrating diarrhoea and potential hospitalisation of their babies due to rotavirus infection anymore, such an infection could still be a death sentence in countries that have not been able to introduce the vaccine in their national vaccination programmes,” she said. 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept